Back to search
FDAFDA · Food and drugs·Recall number D-0127-2019

Irbesartan Bulk Active Pharmaceutical Ingredient.

Published November 7, 2018 · Recall initiated: October 24, 2018

Summary

FDA records drug Class II recall D-0127-2019, published November 7, 2018 and initiated October 24, 2018. Recalling firm: Aurobindo Pharma Limited (Unit I); Status: Terminated; Reported quantity: 1724.8 kgs.; Lot: Manufacturing batch numbers: 1601100782, dispatch batch number 1601101589, exp. date 12/01/2018 1601100783, dispatch batch number 1601101590, exp. date 12/01/2018 1701111861, dispatch batch number 1701113404, exp. date 09/01/2020 1701112170, dispatch batch number 1701113405, exp. date 09/01/2020 1701112501, dispatch batch number 1701113406, exp. date 09/01/2020 1701112056, dispatch batch number 1701113407, exp. date 09/01/2020 1701112558, dispatch batch number 1701114283, exp. date 10/01/2020 1701112559, dispatch batch number 1701114285, exp. date 10/01/2020 1701112589, dispatch batch number 1701114286, exp. date 10/01/2020 1701113300, dispatch batch number 1701114289, exp. date 10/01/2020 1701113301, dispatch batch number 1701114291, exp. date 10/01/2020 1701113302, dispatch batch number 1701114708, exp. date 10/01/2020 1701113312, dispatch batch number 1701114709, exp. date 10/01/2020 1701115460, dispatch batch number 1701117039, exp. date 11/01/2020 1701115974, dispatch batch number 1701117040, exp. date 11/01/2020 1701115460, dispatch batch number 1701117041, exp. date 11/01/2020 1701115738, dispatch batch number 1701117042, exp. date 11/01/2020 1701115739, dispatch batch number 1701117043, exp. date 11/01/2020 1701115740, dispatch batch number 1701117044, exp. date 11/01/2020 1701115741, dispatch batch number 1701117045, exp. date 11/01/2020 1701115742, dispatch batch number 1701117046, exp. date 11/01/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Aurobindo Pharma Limited (Unit I)
Distributor
Product was distributed to one customer in NY.
Lot
Manufacturing batch numbers: 1601100782, dispatch batch number 1601101589, exp. date 12/01/2018 1601100783, dispatch batch number 1601101590, exp. date 12/01/2018 1701111861, dispatch batch number 1701113404, exp. date 09/01/2020 1701112170, dispatch batch number 1701113405, exp. date 09/01/2020 1701112501, dispatch batch number 1701113406, exp. date 09/01/2020 1701112056, dispatch batch number 1701113407, exp. date 09/01/2020 1701112558, dispatch batch number 1701114283, exp. date 10/01/2020 1701112559, dispatch batch number 1701114285, exp. date 10/01/2020 1701112589, dispatch batch number 1701114286, exp. date 10/01/2020 1701113300, dispatch batch number 1701114289, exp. date 10/01/2020 1701113301, dispatch batch number 1701114291, exp. date 10/01/2020 1701113302, dispatch batch number 1701114708, exp. date 10/01/2020 1701113312, dispatch batch number 1701114709, exp. date 10/01/2020 1701115460, dispatch batch number 1701117039, exp. date 11/01/2020 1701115974, dispatch batch number 1701117040, exp. date 11/01/2020 1701115460, dispatch batch number 1701117041, exp. date 11/01/2020 1701115738, dispatch batch number 1701117042, exp. date 11/01/2020 1701115739, dispatch batch number 1701117043, exp. date 11/01/2020 1701115740, dispatch batch number 1701117044, exp. date 11/01/2020 1701115741, dispatch batch number 1701117045, exp. date 11/01/2020 1701115742, dispatch batch number 1701117046, exp. date 11/01/2020
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Irbesartan Bulk Active Pharmaceutical Ingredient. recalled?

Yes. FDA published recall D-0127-2019 on November 7, 2018. Reported hazard: CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.

What should I do if I have this product?

Voluntary: Firm initiated · Letter